Metal–Organic Frameworks‐Based Nanoplatforms for the Theranostic Applications of Neurological Diseases

Huicong Niu,Hui Bu,Jing Zhao,Yufang Zhu
DOI: https://doi.org/10.1002/smll.202206575
IF: 13.3
2023-03-14
Small
Abstract:Neurological diseases are the foremost cause of disability and the second leading cause of death worldwide. Nanoplatforms based on metal–organic frameworks (MOFs) have broadened opportunities for offering sensitive diagnosis/monitoring and effective therapy of neurology‐related diseases. Recent progress including neuroimaging, biosensing, and different treatment strategies and challenges before successful clinical translation are discussed in this review. Neurological diseases are the foremost cause of disability and the second leading cause of death worldwide. Owing to the special microenvironment of neural tissues and biological characteristics of neural cells, a considerable number of neurological disorders are currently incurable. In the past few years, the development of nanoplatforms based on metal–organic frameworks (MOFs) has broadened opportunities for offering sensitive diagnosis/monitoring and effective therapy of neurology‐related diseases. In this article, the obstacles for neurotherapeutics, including delayed diagnosis and misdiagnosis, the existence of blood brain barrier (BBB), off‐target treatment, irrepressible inflammatory storm/oxidative stress, and irreversible nerve cell death are summarized. Correspondingly, MOFs‐based diagnostic/monitoring strategies such as neuroimaging and biosensors (electrochemistry, fluorometry, colorimetry, electrochemiluminescence, etc.) and MOFs‐based therapeutic strategies including higher BBB permeability, targeting specific lesion sites, attenuation of neuroinflammation/oxidative stress as well as regeneration of nerve cells, are extensively highlighted for the management of neurological diseases. Finally, the challenges of the present research from perspective of clinical translation are discussed, hoping to facilitate interdisciplinary studies at the intersections between MOFs‐based nanoplatforms and neurotheranostics.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?
This paper attempts to solve several key problems in the treatment and diagnosis of neurological diseases: 1. **Delayed diagnosis and misdiagnosis**: The early symptoms of neurological diseases are often not obvious, resulting in irreversible damage to nerve cells when patients show clinical symptoms. For example, in patients with Parkinson's disease (PD), approximately 50% of dopaminergic cells have been destroyed before showing typical motor symptoms. Therefore, it is crucial to develop methods for early and accurate diagnosis of neurological diseases. 2. **Existence of the blood - brain barrier (BBB)**: The blood - brain barrier is a highly selective barrier that restricts most drugs from entering the central nervous system (CNS). This makes many effective drugs unable to reach sufficient concentrations in clinical trials, thus affecting the treatment effect. The paper explores how to design nanomaterials that can effectively penetrate the blood - brain barrier. 3. **Nonspecific treatment and side effects**: When drugs are systemically administered, they are often unevenly distributed, with high doses and are prone to adverse reactions. For example, intravenous thrombolysis (IVT), the conventional treatment for acute ischemic stroke (AIS), may lead to bleeding events due to non - targeted activation of plasminogen. The paper discusses how to improve the specificity and biocompatibility of drugs through cell - surface targeting, organ - specific targeting or lesion - microenvironment - targeting strategies. 4. **Inflammatory storm and oxidative stress**: Neuroinflammation and oxidative stress play important roles in many neurological diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), stroke, etc. Although inflammation is involved in the development of most neurological diseases, currently clinically used anti - inflammatory drugs (such as glucocorticoids) are limited to a few traditional inflammatory diseases. The paper proposes the necessity of developing highly effective inflammation inhibitors and free - radical scavengers. 5. **Permanent loss of nerve cells**: Patients with neurological diseases are usually accompanied by different degrees of disability, mainly because of the permanent loss of neurons in the damaged tissue. The paper explores the possibility of using neural stem cells (NSCs) for regenerative treatment to restore and regenerate damaged neurons. To address the above challenges, the paper focuses on the application of metal - organic framework (MOFs) - based nanoplatforms in the diagnosis and treatment of neurological diseases. MOFs have the following advantages: - **Degradability**: Weak coordination bonds make MOFs degradable in complex physiological environments, avoiding long - term accumulation and potential toxicity. - **High loading capacity**: Large pores and high porosity are conducive to high - load drug delivery systems. - **Component adjustability**: By selecting different metal ions / clusters or organic linkers, the size, morphology, composition and chemical properties of MOFs can be adjusted. - **Multifunctionality**: MOFs can be used for multiple functions such as neuroimaging, biosensing, improving BBB permeability, targeting specific lesion sites, inhibiting neuroinflammation / oxidative stress and promoting nerve regeneration. In summary, this paper aims to provide references and guidance for future clinical applications by reviewing the latest progress of MOFs in the diagnosis and treatment of neurological diseases.